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Abstract
Background: Orthosiphon stamineus is used traditionally to treat gout, arthritis, and inflammatory related conditions.
The in vitro anti-inflammatory effects of the plant have been scientifically investigated. The goal of the present study
was to evaluate the potential of the 50% ethanol extract of O. stamineus (EOS) to treat rheumatoid arthritis.
Methods: Anti-arthritic activity was assessed using the in vitro heat denaturation test and the (FCA)-induced arthritis
model. Efficacy was assessed by measurements of paw edema and granulation, X-ray radiography, fluorescence
molecular tomography (FMT), and histological evaluation. Levels of (TNF-α), interleukin-1 (IL-1), and (COX-1 and COX-2)
were analyzed in vitro in lipopolysaccharide (LPS)-stimulated human macrophage (U937). TNF-α and IL-1 levels in the
serum samples of arthritic rats were also measured using an ELISA kit.
Results: Treatment with EOS resulted in dose-dependent inhibition of paw edema in acute and chronic models of
inflammation. It also inhibited significantly the production of TNF-α, IL-1 COX-1, and COX-2 in the LPS-stimulated U937
macrophages. EOS significantly suppressed FCA-induced paw edema as well as the serum levels of TNF-α and IL-1.
X-rays of the synovial joint of the hind leg showed considerable improvement in joint integrity and recovery of
tibia-talus bones from degeneration and osteoporotic lesions. Histology of proximal interphalangeal joints of
EOS-treated animals showed obvious protection of cartilage and soft tissue. Finally, FMT analysis strongly supported
the anti-arthritic effect of EOS. EOS had high phenolic and total flavonoid content as well as strong antioxidant activity.
Conclusions: Results illustrated that the anti-arthritic properties of O. stamineus could be beneficial for prevention and
management of rheumatoid arthritis and other chronic inflammatory disorders.
Keywords: Anti-arthritis, Anti- inflammatory, Orthosiphon stamineus, Fluorescence Molecular Tomography (FMT),
Pro-inflammatory mediators
Background
Arthritis is an autoimmune disorder that encompasses a
group of systemic diseases that target and attack the ar-
ticular joints of the body, leading to erosive inflamma-
tion in the synovial membranes. Arthritis is considered
to be one of the leading causes of disability in people of
all ages [1, 2]. Rheumatoid arthritis (RA) is a conse-
quence of erosive synovitis, neovascularisation, and
synoviocyte hyperplasia, which lead to articular cartilage
and joint destruction [3]. Recently, the number of people
diagnosed with arthritis has significantly increased to 60
million cases worldwide, with more women being af-
fected than men, and 60–90% of patients use herbal
remedies to treat their symptoms. The use of traditional
medicinal herbs and alternative medicines is on the rise
because of the many severe side effects associated with
use of non-steroidal anti-inflammatory drugs (NSAIDs),
including the risk of gastrointestinal and cardiovascular
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complications [4]. Standardized herbal extracts work on
multiple targets to both cure the disease and avoid the
side effects of NSAIDs.
Orthosiphon stamineus Benth. (Lamiaceae), locally
known as “Misai Kucing” or cat’s whiskers, is a trad-
itional medicinal herb used in southeast Asia to treat
various inflammatory diseases such as cancer, hepatitis,
rheumatism, abdominal pain, psoriasis, hyperlipidemia,
diabetes, and kidney stones [5]. In Europe, people use a
decoction of leaves of O. stamineus to make java tea to
improve general health and fitness [6]. Scientific studies
have reported the presence of bioactive pentacyclic
triterpenes, betulinic acid, oleanolic acid, ursolic acid,
β-sitosterol, and more than 20 other phenolic com-
pounds in the leaves of this plant [7]. Recently, the po-
tent antiangiogenic activity of O. stamineus and its
prevention activity against human breast tumors in a
xenograft model were reported [8]. Another study
reported that the ethanol extract of O. stamineus spe-
cifically inhibited vascular endothelial growth factor
(VEGF) expression and VEGF receptor (VEGFR) phos-
phorylation, which are known to be up-regulated
during new blood vessel formation. O. stamineus also
suppressed vascularization and inhibited growth of
implanted human colon tumors. The high amount of
rosmarinic acid in the ethanolic extract of O. stamineus
played a main role in these activities [9]. The ant-
inflammatory properties of O. stamineus leaf chloro-
form extract have been scientifically proven, it shows a
potent in vitro inhibition to pro-inflammatory media-
tors expression such as iNOS, COX-2 and TNF-α, as
well as PGE2 and NO production [10]. In addition, fla-
vonoid rich chloroform extract fraction of O. stamineus
inhibits the production of prostaglandin and NO, the
activity ascribed to the rich contents of flavonoids,
sinensetin and eupatorin,. Treatment with the fraction
causes reduction of Rat hind paw edema [11]. In vivo
treatment with O. stamineus demonstrated significant
inhibitions activities against TPA -induced inflamma-
tion to mouse ears [12]. Another in vivo study using
hexane fraction of O. stamineus confirmed the potent
inhibition of carrageenan induced paw edema in rat
[13, 14]. To the best of our knowledge, there is no anti-
inflammatory, in vitro and in vivo anti-arthritis have
been reported using 50% ethanol extract.
The objective of this study was to investigate the anti-
arthritis, antioxidant, and anti-inflammatory properties of
the 50% ethanol extract of O. stamineus leaves (EOS). The
mechanisms that underlie the anti-arthritic properties of
EOS were assessed using in vitro and in vivo animal
models, and fluorescence molecular tomography (FMT)
and X-ray in vivo imaging were used to evalute the anti-
arthritic efficacy of the extract. The carrageenan-induced
rat paw edema model for acute inflammation and the
cotton pellet-induced granuloma model for sub-chronic
inflammation were used to evaluate the effects of EOS on
inflammation. Total flavonoid,Total phenolic, DPPH,
ABTS and FRAP used to determine the antioxidant effi-
cacy of EOS.
Methods
Cell culture reagents and conditions
The U937 human macrophage cell line and fetal bovine
serum (FBS) were purchased from the American Type
Culture Collection (Masassas, VA, USA). RPMI 1640 and
penicillin/streptomycin were procured from Invitrogen
(Carlsbad, CA, USA). Potassium chloride (KCl) and hydro-
chloric acid (HCl) were obtained from BDH Chemicals
Ltd. (Poole, United Kingdom). PMA (phorbol 12-myristate
13-acetate), 2,2’-diphenyl-1-picrylhydrazyl (DPPH), gallic
acid, Folin-Ciocalteu reagent, sodium carbonate (Na2CO3),
lipopolysaccharide,and quercetin were purchased from
Sigma Aldrich (Germany). Aluminum chloride (AlCl3),
potassium acetate, sodium nitrate, sodium hydroxide, and
2,2-azinobis (3-ethylbenzothiazoline-6- sulfonic acid)
(ABTS) were purchased from Merck (Germany). Diammo-
nium salt, 2,4,6-Tri (2- pyridyl)-s-triazine (TPTZ), ferric
chloride (FeCl3), and potassium persulfate were obtained
from Sigma Aldrich (Poole, Dorset, UK). Chloroform was
obtained from R & M Marketing (Essex, UK). Methanol
and absolute alcohol were purchased from Riedel-de Haën
(Seelze, Germany), and λ-carrageenan was procured from
Sigma Aldrich (St. Gallen, Switzerland).
Experimental animals
Male Sprague Dawley rats (150–200 g) were obtained
from the Animal Research and Service Centre, Universiti
Sains Malaysia (USM). The animals were kept in the
animal transit room at the School of Pharmaceutical
Sciences, USM (12 h dark/light cycle, 40–60% relative
humidity, and 25 °C temperature). The animals were
provided free access to food and water. However, the
food was withdrawn 12 h before any experimental pro-
cedure was conducted on the animals. The experimen-
tal work was consistent with guidelines of the USM
Committee for Animal Care and received approval
from the USM Animal Ethical Committee (USM/PPSF/
50 (084) Jld.2).
Plant material and extraction procedure
Leaves of O. stamineus were obtained from a contract
farming facility in Penang, Malaysia. O. stamineus were
studied and confirmed by the Senior Botanist Mr.
Shanmugan, School of Biological Sciences, USM. The
specimen (Voucher No.: 11009) was deposited at the
herbarium of the School of Biology, USM. The 50%
ethanol extract of the O. stamineus leaves (EOS) was
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prepared using the maceration process as previously
described [8].
Phytochemical study of EOS
Determination of total phenolic content
Folin-Ciocalteu reagent was used to determine the total
soluble phenolic content of EOS. Gallic acid was used as
the standard according to the method of [15].
Determination of total flavonoid content
The AlCl3 colorimetric method was used to determine
the total flavonoid content of EOS, and quercetin was
used as the positive control as described before [16].
Ferric reducing antioxidant power (FRAP) assay
The antioxidant capacity of EOS was determined using
the FRAP assay following the method described by [17].
ABTS assay
The ABTS radical scavenging capacity assay was con-
ducted according to the procedures described by [18, 19].
Free radical scavenging (FRS) activity
The antioxidant activity of EOS also was evaluated by
measuring its ability to scavenge the stable free radical
DPPH following a previously described technique with
minor modifications [20].
In vitro anti-inflammatory assay of effects of EOS
Cell proliferation assay
The MTT assay was used to assess the effect of EOS on
U937 cells using a previously described technique with
minor modifications [21–23].
Cell viability assay
Viability of cells was determined using the trypan blue
exclusion method as described before [24, 25].
Analysis of cytokine levels in differentiated human
macrophages
Differentiated human macrophages (100 μl, 2 × 105
cells/ml) were seeded into 96-well flat-bottom plates in
the presence or absence of LPS (1 μg/mL) for 24 h. The
macrophages were treated with 100 μl of various con-
centrations of EOS (12.5, 25, 50, 100, and 200 μg/ml).
The plates were incubated at 37 °C under 5% CO2.
After 48 h, the plates were centrifuged at 1000 rpm for
10 min. Next, 100 μL of supernatant were used to
measure the concentration of interleukin 1 (IL-1) and
tumor necrosis factor (TNF-α). The optical densities of
the samples were measured using the Tecan Infinite
pro200 microplate reader at 550 nm. The calibration
curves of standards were used to calculate the concen-
tration of IL-1 and TNF-α in the samples [25].
In vitro cyclooxygenase (COX) inhibition assay
The effect of EOS on COX was assessed using enzyme-
based kits purchased from Cayman Chemicals (Ann
Arbor, MI, USA) according to the method described
before [26].
In vivo acute anti-inflammatory assay
The acute anti-inflammatory effect of EOS was evaluated
using the carrageenan-induced rat hind paw edema
model as mentioned before [27].
In vivo sub-chronic cotton pellet granuloma model in rats
Granuloma tissue formation was used to study the anti-
inflammatory effect of EOS following the method de-
scribed before with minor modifications [28].
Anti-arthritis properties of EOS
Inhibition of albumin denaturation
In this assay, The percentage inhibition of protein de-
naturation was calculated following the reference [29, 30].
Freund’s Complete adjuvant (FCA)-induced arthritis in rats
Wistar rats (150–200 g) of either sex were used in this
experiment. Grouping was the same as that illustrated
above (Cotton pellet granuloma model). The experiment
was carried out as described by [31, 32]. The rats were
anesthetized and X-ray radiographs were recorded on a
digital system.
Fluorescence Molecular Tomography (FMT)
A chronic in vivo arthritis model using FCA-induced
mice was used to detect and quantify fluorescent agents
in EOS-treated and non-treated groups of mice. The ani-
mals were injected subcutaneously with 0.03 ml of FCA
into the plantar region of the left hind paw. Diclofenac
sodium (5 mg/kg) was used as the positive control. EOS
at 200 and 400 mg/kg were administered daily for 21 d.
On day 21, 100 μL of ProSenes Perkin Elmer fluorescent
imaging probe were injected into the tail vein of each
mouse. After 24 h, the animals were anaesthetized using
Phenobarbital. Each mouse was placed in the portable
animal imaging cassette of the FMT and imaged using a
Molecular Light Imager (Berthold Technologies) for
10 ms using a HQ 470 excitation filter (Chroma), HQ
525 emission filter (Chroma), and the WinLight32 soft-
ware supplied with the instrument. Imaging was then
performed using a two-step process and the WinLight32
software. First, a black and white photographic image
was acquired using a 15 ms exposure. Next, the fluores-
cent image was acquired using a 5 min photon in-
tegration period with background subtraction. The
fluorescent image was processed to colorize the fluores-
cence intensity, and then it was overlaid onto the black
and white image for presentation. Quantification of the
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images was conducted, and the data were used to
characterize the extent of the anti-arthritic effect and
protection provided by EOS against the FCA-induced
arthritis [33, 34].
Statistical analysis
Data obtained from in vitro and in vivo experiments are
expressed as mean ± SD. Statistical differences between
the treatments and the control were evaluated by one-
way analysis of variance followed by Tukey’s multiple
comparison test using IBM SPSS software (Version 20).
Differences were considered to be significant at p < 0.05
and p < 0.01.
Results
EOS contains high amounts of total phenolic and total
flavonoid compounds
The total phenolic content of EOS (expressed as mg
gallic acid equivalent per gram of EOS) was 385.092 ±
1.4 μg/mL. The total flavonoid content (mg quercetin
equivalent per gram of EOS) was 57.185 ± 3.0 μg/mL.
The result is presented as mean ± SD of 3 independent
experiments in 3 replicates each.
Free radical scavenging capabilities of EOS
The total reducing capacity of EOS was measured using
the FRAP assay, which is based on a compound’s ability
to reduce the Fe3+/tripyridyltriazine complex to a ferrous
form (blue colored). The results of the FRAP study
showed that EOS at 1.0 ± 0.1 μg/ml had effective redu-
cing power. Similarly, scavenging ability of EOS was
evaluated using the DPPH and ABTS assays. EOS had
potent DPPH quenching activity (IC50 14.87 ± 1.2 μg/ml)
and ABTS quenching activity (IC50 = 15.98 ± 1.3 μg/ml).
The standard reference, vitamin C, had IC50 values of
9.8 ± 0.38 and 4.2 ± 0.4 μg/ml in the DPPH and ABTS
assays respectively (Table 1). The result is presented as
mean ± SD of 3 independent experiments in 3 replicates
each.
Anti-inflammatory effects of EOS
Effect of EOS on proliferation of U937 cells
The antiproliferative potency of EOS was evaluated
using the U937 cell line and the MTT assay. EOS signifi-
cantly inhibited proliferation of U937 cells (IC50 91.0 ±
2.3 μg/ml). The result is presented as mean ± SD of 3 in-
dependent experiments in 3 replicates each.
In vitro inhibitory effect of EOS on production of IL-1 and
TNF-α in U937 cells
ELISA was used to assess the in vitro effect of EOS on the
inflammatory mediators in LPS-stimulated macrophages
(i.e., U937 cells). EOS caused moderate significant (p < 0.05)
inhibition of the levels of the proinflammatory cytokines
IL-1 and TNF-α (IC50 88 ± 1.9 and 63 ± 1.4 μl/ml, respect-
ively). EOS also showed a dose-dependent inhibitory effect
on IL-1 and TNF-α levels in these cells. The data is
presented as mean ± SD of 2 independent experiments in 5
replicates each. *** p < 0.001, ** p < 0.01, * p < 0.05 vs. nega-
tive control.
In vitro inhibitory effect of EOS on COX-1 and COX-2
activities
The anti-inflammatory effect of EOS was determined
using in vitro COX inhibition assay kits. EOS strongly
inhibited both COX-1 and COX-2 activities. The inhib-
ition of COX-1 by EOS at 50 and 200 μg/mL was 22.7 ±
0.8% and 52.6 ± 2.8%, respectively, whereas the values
for COX-2 were 83.1 ± 1.3 and 99.7 ± 0.02%, respect-
ively. The standard reference, celecoxib (0.05 μM) dis-
played potent inhibitory effect on COX-2 with 37 ± 2%
whereas, acetyl salicylic acid (0.1 μM) showed 98.8 ± 1%
on COX-1 (Fig. 1).
Inhibitory effect of EOS on carrageenan-induced paw
edema in rats
The carrageenan-induced rat hind paw edema model
was used to assess the anti-inflammatory effect of EOS
in comparison with the standard reference drug indo-
methacin. The results show the percent inflammation
recorded 3 h after carrageenan administration in the
rats from different test groups. Inflammation was dras-
tically reduced in the treated groups. The percent in-
flammation values of treatment with 100, 200, and
400 μg/ml of EOS were 49 ± 2.2%, 67 ± 1.8%, and 78 ±
2.7%, respectively, and indomethacin treatment resulted
in 58 ± 3% inhibitions at 5 mg/kg. The data is presented
as mean ± SD of 2 independent experiments in 6 repli-
cates each. ** p < 0.01, * p < 0.05 vs. negative control.
Inhibitory effect of EOS on cotton pellet-induced granuloma
in rats
Granulation tissue was induced by subcutaneous implant-
ation of cotton pellets in rats. Treatment with EOS signifi-
cantly inhibited the inflammation in rats. The percent
inhibition values of granuloma tissue were 15.8, 21.6, and
34.5% for EOS doses of 100, 200, and 400 μg/kg, res-
pectively. Indomethacin and dexamethasone significantly
inhibited granuloma tissue by 38.6 and 57.2%, respectively.
Treatment with different amounts of EOS produced sta-
tistically significant dose-dependent inhibition of weight
Table 1 Results of the DPPH, ABTS, and FRAP assays
Test DPPH ABTS FRAP
EOS (μg/ml) 14.87 ± 1.2 15.98 ± 1.3 1.0 ± 0.1
Vitamin C (μg/ml) 9.8 ± 0.38 4.2 ± 0.4 -
Tabana et al. BMC Complementary and Alternative Medicine  (2016) 16:480 Page 4 of 11
of the cotton pellet (p < 0.001). Figure 2 shows mean
weight of the cotton pellets dissected from the tested rats.
In vivo inhibitory effect of EOS on production of IL-1 and
TNF-α in rats
Levels of the inflammatory mediators IL-1 and TNF-α in
blood collected from the treated and control animals
were measured using ELISA. The results were in agree-
ment with that of the in vitro study described above.
Treatment with EOS caused a significant decrease in the
contents of these serum inflammatory mediators when
compared to the control (p < 0.01). EOS treatment also
showed dose-dependent inhibitory effects. At 100, 200,
and 400 mg/kg of EOS, the levels of IL-1 were 78.6 ±
2.7, 92.7 ± 0.1, and 96 ± 0.2%, respectively, compared
with indomethacin (89.8 ± 1.9%). The percent inhibition
of serum TNF-α by the 100, 200, and 400 mg/kg doses
of EOS were 56.8 ± 2, 69.5 ± 1.6, and 70.5 ± 1%, respect-
ively. The levels in the treatment groups were compar-
able to that of the standard reference, indomethacin
(78.5 ± 4) (Fig. 3).
Anti-arthritis properties of EOS
Inhibitory effect of EOS on albumin denaturation in vitro
Anti-arthritis activity was studied using an in vitro inhib-
ition of protein denaturation assay, as the relationship
between protein denaturation and arthritis was docu-
mented recently. In vivo denaturation of protein leads to
increasing production of auto-antigen, which causes the
disease. The three concentrations of EOS (100, 200, and
400 μg/ml) tested provided significant protection against
protein denaturation (78.8 ± 1, 88.5 ± 3.6, and 93.7 ±
3.4%, respectively). Acetyl salicylic acid (250 μg/ml) re-
sulted in 42.7 ± 3.1% inhibition of protein denaturation
(Table 2).
Inhibitory effect of EOS on FCA-induced paw edema in rats
Injection with FCA of the right hind paw of rats
leads to an increase in the size of the joint. Max-
imum joint swelling was observed in all groups on
the second day after immunization. Chronic treatment
Fig. 1 Results of the prostaglandin concentration in vitro colorimetric assay of the effects of EOS and standard drugs on the activities of COX-1
and COX-2 enzymes. Two EOS concentrations were used (50 and 200 μg/mL). The standard drugs used were acetyl salicylic acid (0.1 μM) for
COX-1 whereas, celecoxib (0.05 μM) for COX-2. The results are presented as mean ± SD of 2 independent experiments in 5 replicates each.
*** p < 0.001, ** p < 0.01, * p < 0.05 vs. control
Fig. 2 a Size of cotton pellets differed between control and treated
animals. b Average Granuloma weight in the respective test groups
also differed. Indomethacin was used as the positive control. The
data is presented as mean ± SD of 2 independent experiments in 6
replicates each. * p < 0.05 vs. negative control
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with EOS effectively reduced the lesions in arthritic
rats. The major reduction of joint swelling was de-
tected on day 21 in rats treated with EOS and the
positive control (Fig. 4).
Radiographs of the paw 21 d after treatment with FCA
X-rays of the synovial joint of the hind leg of FCA-
treated rats revealed significant numbers of osteopore-
tic lesions and bone degeneration. The X-ray image
shows marginal swelling in the bone and slight destruc-
tion of the cartilage 21 d after treatment (Fig. 5b). In
contrast, the radiographic images of rats treated with
high doses (200 and 400 mg/kg) of EOS and those
treated with diclofenac sodium showed no callus for-
mation, deformity, or irregular margins of cartilage and
bone, which illustrates the significant pharmacological
anti-inflammatory action of EOS compared to the con-
trol (Fig. 5b).
Histopathological changes of the paw 21 d after treatment
with FCA
The rats were sacrificed via anesthesia on day 21. Knee
joints and hind paws were removed from the rats and
fixed in 10% PBS, Serial paraffin sections (5 mm) were
stained with hematoxylin and eosin. The rats treated
with EOS and diclofenac sodium showed significant re-
duction in synovial hyperplasia, inflammation, and ero-
sion of the synovial membrane and cartilage compared
with the control group (Fig. 5c).
The degree of histologic changes was graded semi-
quantitatively on a scale of 0-3 points [35], 0 corre-
sponding to “not present, i.e. normal”, whereas 1 = mild,
2 =moderate, 3 = severe. Accordingly, the changes in
each test group were then summed up. The pathological
characteristics of synovial membrane included were as
follows,
1) Hyperplasia in Synovial membrane.
2) Presence of multinucleated Synovial giant cells.
3) Presence of inflammatory cell.
4) Presence of granuloma tissue including destruction
of the articular cartilage and bone.
5) Loss of collagen fibrils or presence of necrosis.
FMT
FCA elicits inflammation by stimulating proinflamma-
tory mediators, thus it can provide quantitative informa-
tion about inflammatory joint disease development in
the mouse RA model. It is well know that cathepsins are
upregulated in inflammatory diseases particularly in
rheumatoid arthritis. In the present study, FMT system
was used to quantify the cathepsins which are the spe-
cific aspects of rheumatoid arthritis and osteoporosis.
The FMT scanning analysis showed significantly high in-
tensity of fluorescent signal in the negative control ani-
mals bearing chronic inflammation induced by the FCA.
Whereas, treatment with EOS showed a dose-dependent
reduction of the fluorescence intensity. These results can
be compared with the standard reference drug, indo-
methacene (Fig. 6).
Fig. 3 Inhibitory effect of EOS (100, 200, and 400 mg/kg) and the standard drug (indomethacin) on the activities of TNF-α and IL-1 in the plasma
samples of rats. The results are presented as mean ± SD of 2 independent experiments in 5 replicates each. * p < 0.005, ** p < 0.01 vs. control
Table 2 Percentage inhibition of protein denaturation by three
concentrations of EOS
Groups (μg/ml) Protein denaturation (%)
EOS 100 78.8 ± 1*
EOS 200 88.5 ± 3.6***
EOS 400 93.7 ± 3.4**
Acetyl salicylic acid 42.7 ± 3.1
Acetyl salicylic acid (250 μg/ml) was used as the positive control. The data is
presented as mean ± SD of 3 independent experiments in 3 replicates each.
*** p < 0.001, **p < 0.01, *p < 0.05 vs. negative control
Tabana et al. BMC Complementary and Alternative Medicine  (2016) 16:480 Page 6 of 11
Fig. 4 The effect of EOS on paw swelling (mm) in rats induced by FCA during 21 d of treatment. Treatment with EOS resulted in profound
inhibition of the tibio-tarsal joint diameter compared with negative control animals. The results are presented as mean ± SD of 2 independent
experiments in 6 replicates each
Fig. 5 Anti-arthritic efficacy of EOS in FCA-induced arthritic rats. a Clinical symptoms (left panels), b X-rays (middle panels), and c histological analysis
(right panels, hematoxylin and eosin stained) of FCA-induced arthritic rats treated with distilled water (negative control), different doses of EOS (100,
200, and 400 mg/kg), and diclofenac sodium (positive control). FCA injection induced severe inflammation and bone destruction, which were
evidenced via paw edema, bone degeneration, and osteoporotic lesions (arrows). Treatment with EOS suppressed hind paw swelling and
bone destruction. Histological sections from the negative control group showed severe synovitis marked by the loss of cartilage tissue and
the presence of numerous macrophages. Total score for synovitis recorded for the negative control group is 13 points. However, treatment
with EOS significantly reduced the number of macrophages and increased the production of collagen fibrils (arrow heads). Total score for
synovitis recorded for 100, 200 and 400 mg/kg doses of EOS are 10, 7 and 3 points, respectively. The anti-arthritic effect of EOS was comparable to
that of diclofenac sodium (total score for synovitis recorded is 4 points). The data is presented as mean ± SD of 2 independent experiments in 6
replicates each
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Discussion
O. stamineus is a traditional medicinal herb with various
and dynamic medicinal properties [9, 36]. It has been
used in traditional medicines to treat inflammatory-
related disorders such as renal nephritis, cancer, and
arthritis [8]. Although the plant is widely used as a folk
remedy to treat arthritis and several in vitro studies of
the anti-inflammatory properties of the herb have been
reported [37]. Two compounds have anti-inflammatory
properties, pimarane diterpenes, orthosiphol A and B,
have been isolated from the plant [12], mechanistic stud-
ies of its effects on arthritis using a suitable in vitro and
in vivo model are lacking. Thus, the present study was
conducted to investigate the anti-arthritis properties of
EOS and to correlate the in vitro antioxidant and anti-
inflammatory potentials of EOS with its inhibitory effect
on paw edema and granuloma in rats.
Antioxidant activities of EOS
Antioxidants are compounds that protect cells against the
damaging effects of reactive oxygen species such as perox-
ynitrite, superoxide, singlet oxygen, hydroxyl, and peroxyl
radicals. Cellular damage occurs due to the imbalance
between antioxidants and reactive oxygen species, which
takes place because of exposure of a biological system to
highly reactive free radicals generated by exogenous
agents (e.g., radiation, chemicals, hyperoxia) and endogen-
ous processes such as normal cellular metabolism [38]. It
is linked to inflammation, cancer, atherosclerosis, aging,
ischemic injury, and neurodegenerative diseases [39]. Nat-
ural antioxidants have garnered increasing interest among
consumers and the scientific community because epi-
demiological studies have indicated a lower risk of cardio-
vascular disease and cancer when natural antioxidants are
consumed frequently [40, 41]. We found that EOS has
potent antioxidant activities based on its capacity to re-
duce ABTS+ (IC50 16.16 μg/ml), its ability to reduce the
Fe3+/tripyridyltriazine complex to its blue-colored ferrous
form (FRAP) (1.0 μg/ml), and its ability to scavenge DPPH
(IC50 14.8 μg/ml) (Table 1).
The special effects of phenolic and flavonoid com-
pounds in plants on antioxidants also have been re-
ported. The redox properties of these compounds are
responsible for their main effects. EOS contains high
amounts of total phenolic and flavonoid compounds
(350 ± 0.6, 131 ± 0.9, respectively).
Fig. 6 a & b FMT tomographic imaging or rat paws to assess arthritis disease severity using ProSense fluorescent imaging agent. (1 & 6)
Tomographic images of normal control without FCA treatment. (2) The fluorescent signal of the negative control is represented as a maximum
intensity projection. (3) Result for the group treated with the low concentration (200 mg/kg) of EOS. (4) Results for the group treated with the
high concentration (400 mg/kg) of EOS. (5) Result for the group treated with the positive control, diclofenac sodium (5 mg/kg). c Quantifications
of paw fluorescence for each of the two EOS doses and the positive and negative controls. The data is presented of 2 replicates each
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Anti-inflammatory activity of EOS
The present study was conducted to investigate the anti-
inflammatory potential of EOS, which likely is respon-
sible for the wide range of pharmacological properties of
this herb, and to correlate its in vitro antioxidant and
anti-inflammatory properties with its inhibitory effect on
paw edema and granulation tissue in rats. Proinflamma-
tory mediators such as TNF-α and IL-1 play significant
roles in the pathophysiology of arthritis [42]. TNF-α is
one of the most important inflammatory cytokines, as it
controls different types of cell functions. The overpro-
duction of TNF-α is linked to the development of vari-
ous diseases such as asthma, RA, psoriatic arthritis,
inflammatory bowel disease, septic shock, diabetes, and
atherosclerosis [43]. Inflammatory mediators such as IL-
1 are also essential in synovcyte destruction in different
immunoinflammatory diseases such as RA [44]. Both
TNF-α and IL-1 induce the production of high levels of
matrix metalloproteinases by synovial cells and chondro-
cytes [45]. COX-2 is highly inducible by serum, growth
factors, lipopolysaccharides, and cytokines, especially IL-
1, in certain cell types involved in the inflammatory
processes (e.g., fibroblasts and macrophages). IL-1β in-
creases the synthesis of COX-2, which plays a significant
role in the overproduction of prostaglandin E2, thereby
leading to arthritis [46].
In the present study, treatment with EOS resulted in a
significant in vitro reduction of IL-1 and TNF-α levels
(IC50 values of 88 ± 1.9 and 63 ± 1.4 μl/ml, respectively)
as well as in vivo dose-dependent inhibitory effects
(Fig. 3). On the other hand, TNF-α and IL-1 collectively
interact with COX-2 to activate the immune system. In-
duced inflammation in the in vivo animal model sug-
gests that the produced edema is associated with the
accumulation of COX-2 mRNA and thromboxane. As a
result, inhibition of COX-2 is considered to be a main
approach to treating inflammation [47]. In the current
study, EOS treatment caused significant suppression of
COX-1 and mainly COX-2 activities (52.6 ± 2.8% and
99.7 ± 0.02%, respectively). Moreover, treating the
carrageenan-induced edema in the rat paw with EOS re-
sulted in a potent reduction of swelling and inflamed
paw. These results suggest a correlation between the
anti-inflammatory ability of EOS and its effectiveness in
reducing COX-2 levels. The inhibitory effects of COX-2
give EOS a high therapeutic safety used to avoid gastro-
intestinal (GI) adverse effects of other ant-inflammatory
drugs [48]. To evaluate the efficacy of the extract against
the later proliferative phase of inflammation that results
in tissue degeneration and proliferation of macrophages,
neutrophils, fibrosis, and multiplication of small blood
vessels, we conducted the cotton pellet granuloma test.
The granuloma test is a dependable in vivo model that is
widely used to study chronic inflammation [49]. EOS
treatment resulted in decreased granuloma weight,
which indicates that the extract suppressed cell prolifer-
ation (Fig. 2).
Anti-arthritis activity of EOS
Arthritis is a chronic inflammatory disease that targets
all joints in the body causing erosions in the lining of
the joint [50]. Several models to study arthritis have
been reported. One of the most used is called FCA-
induced arthritis. It assesses subchronic or chronic in-
flammation in rats and is of considerable relevance for
the study of pathophysiology and pharmacological con-
trol of inflammatory processes [51]. This model acts by
lengthening the life span of the injected autoantigen,
stimulating autoantigen delivery to the immune system,
and giving a group of signals to the innate compartment
of the immune system, resulting in proliferation and
differentiation of leukocytes [52]. The efficacy of anti-
arthritic drugs and herbal products can be tested and
validated using parameters such us paw swelling meas-
urement, cytokine profiles, chemokine profiles, bone re-
modeling molecules, functional disability, spleen weight,
X-ray, and histopathology of the paw [53, 54].
Several medicinal plants have been reported for their
potential application in the treatment of arthritic inflam-
mation and bone damage, and herbal remedies are
widely used in preclinical and clinical studies [31, 55]. In
the current study, EOS demonstrated potent in vitro and
in vivo anti-arthritic activity. It protected against de-
naturation of protein, which controls the production of
autoantigen and is considered to be one of the basic
causes of RA (Table 2). Denaturation may involve alter-
ation of electrostatic, hydrogen, hydrophobic, and disul-
phide bonding [56]. The effect of EOS could be due to
the presence of phenolic and flavonoid compounds and
to the high antioxidant activities of EOS (Table 1).
In vivo findings showed that EOS suppressed the
chronic phase of inflammation when compared with
the FCA control group. The animals treated with EOS
(100, 200, and 400 mg/kg) and diclofenac sodium
(5 mg/kg) showed a significant reduction in the size of
the Granuloma
After 21 d of treatment, the inflammatory mediators
COX-1/2 and IL-1β in the synovial membrane are
closely associated with the degree of edema. [57]. The
changes in the left paw edema size in EOS treatment vs.
control groups over time showed that EOS strongly
inhibited inflammation, likely due to the presence of
high amounts of flavonoid and phenolic compounds. In
addition, EOS treatment strongly suppressed inflamma-
tory mediators such as IL-1, TNF-α, COX-1 and COX-2
as described above. The radiographic images of the
negative control animals showed swelling, destruction of
cartilage, and erosion of the synovial membrane and
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articular meniscus. However, groups treated with the
positive control and EOS (200 and 400 mg/kg) did not
show any of these signs. Moreover, histopathological
evaluation of the treated groups showed no synovial
hyperplasia or erosion of the synovial membrane and
cartilage relative to the control group.
FMT has been used to assess tumor, inflammatory, pul-
monary, cardiovascular, and skeletal diseases. This technique
provides non-invasive, whole body, deep tissue imaging in
small animal models, and in this study it generated three-
dimensional information-rich results to evaluate the efficacy
of EOS against chronic inflammation and arthritis [58]. The
pros of using FMTare that it provides a good understanding
of the mechanism and progression of diseases and it supports
results from other models. It yields sensitive readouts regard-
ing the pathology of the disease, and that it may prove possible
to apply FMT results to predict disease development. It has
been already proved that Cathepsin plays a crucial role in
pathogenesis of different disorders of inflammation specific-
ally rheumatoid arthritis (RA) whereas it may cause bone ero-
sion and cartilage degradation in RA joints, increasing the
activity of Cathepsin in synovial membranes involves poten-
tially in cartilage degradation and bone destruction [59]. Ca-
thepsin is mainly induced by inflammatory mediators such as
TNF-α, IL-1 and –6. In the current study, we have proven the
significant reduction of TNF-α, IL-1. As ProSenes is activated
by the key disease associated proteases, Cathepsin, FMT sys-
tem was applied to quantify the cathepsins to study disease
progression and therapeutic response in animal models of
arthritis. FMT results showed significantly reduction in the in-
tensity of fluorescent signal in the treated groups which is re-
sembles the reduction of cathepsins. Our findings were
consistent with the histology andX-ray results.
Conclusion
In conclusion, treatment with EOS significantly sup-
pressed acute and chronic inflammation induced in rats.
Treatment of FCA-induced arthritic rats with EOS also
provided protection of bone, cartilage, and soft tissues
from inflammatory damage. Histological analysis re-
vealed regeneration of collagen fibrils and suppression of
macrophage levels at the inflammatory site in EOS-
treated animals. In addition, EOS treatment reduced the
levels of inflammatory markers such as TNF-α, IL-1,
COX-1, and COX-2 in human macrophages and arthritic
rats, suggesting that EOS may suppress these inflamma-
tory mediators. Thus, results of this study demonstrate a
potential use of O. stamineus for the treatment of arth-
ritis and other inflammatory disorders.
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